Review Registration - Organization

This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.

Registration ID: 1106724
Submitted by lobbyist on: February 4, 2020 08:13:11 AM
Accepted by Registrar on: February 4, 2020 04:00:30 PM

Designated Filer Information

Robidoux, Michel  
110 rue de Lauzon  
Boucherville, QC, J4B 1E6
450-641-4903
Canada  

Organization Information

Sandoz Canada Inc.  
Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to discover new ways to improve and extend people's lives. For further information please visit www.sandoz.ca
110 rue de Lauzon  
Boucherville, QC, J4B 1E6
450-641-4903
Canada  

Relevant Affiliates


Type:

Business Name Mailing Address Contact Information
Novartis Pharmaceuticals Inc. 385 Boul Bouchard
Dorval, QC
H9S 1A9
Canada
Phone: 514-631-6775

Government or Government Agency Funding


The organization does not receive any funding from a government or government agency.

Other Controlling or Directing Interests

The organization has no other controlling or directing interests.

Active Registration Period

February 4, 2020  
August 4, 2020  

Organization's In-House Lobbyists

 



Name: Ciampi, Vincenzo
 
February 4, 2020  

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Development, establishment, amendment or termination of any program, policy or decision

Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness to government officials of generics and Biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and Biosimilars. Improve regulatory environment to allow pharmacies in British Columbia to sell and distribute medical cannabis to patients.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Darcy, Judy Minister of Mental Health and Addictions February 4, 2020
Minister Dix, Adrian Minister of Health February 4, 2020
Minister Eby, David Minister of Attorney General February 4, 2020
Public Agency Health February 4, 2020
Public Agency Mental Health and Addictions February 4, 2020

Name: Ferreira, Leonor
 
February 4, 2020  

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness to government officials of generics and Biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and Biosimilars.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency Health February 4, 2020

Name: Matteau, Karine
 
February 4, 2020  

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Development, establishment, amendment or termination of any program, policy or decision

Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness to government officials of generics and Biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and Biosimilars.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Dix, Adrian Minister of Health February 4, 2020
Staff of Minister Singh, Jasmyn Minister of Health February 4, 2020
Public Agency Health February 4, 2020

Name: Ouellet, Christian
 
February 4, 2020  

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Development, establishment, amendment or termination of any program, policy or decision

Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness to government officials of generics and Biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and Biosimilars. Improve regulatory environment to allow pharmacies in British Columbia to sell and distribute medical cannabis to patients.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Darcy, Judy Minister of Mental Health and Addictions February 4, 2020
Minister Dix, Adrian Minister of Health February 4, 2020
Minister Eby, David Minister of Attorney General February 4, 2020
Minister Horgan, John Premier February 4, 2020
Minister James, Carole Minister of Finance February 4, 2020
Staff of Minister Singh, Jasmyn Minister of Health February 4, 2020
MLA Cadieux, Stephanie Surrey South February 4, 2020
MLA Isaacs, Joan Coquitlam-Burke Mountain February 4, 2020
MLA Yap, John Richmond-Steveston February 4, 2020
Public Agency Health February 4, 2020
Public Agency Mental Health and Addictions February 4, 2020
Public Agency University of British Columbia February 4, 2020

Name: Pedro, Carmen
 
February 4, 2020  

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Development, establishment, amendment or termination of any program, policy or decision

Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness to government officials of generics and Biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and Biosimilars.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency Health February 4, 2020

Name: Robidoux, Michel
 
February 4, 2020  

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Development, establishment, amendment or termination of any program, policy or decision

Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness to government officials of generics and Biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and Biosimilars. Improve regulatory environment to allow pharmacies in British Columbia to sell and distribute medical cannabis to patients.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Darcy, Judy Minister of Mental Health and Addictions February 4, 2020
Minister Dix, Adrian Minister of Health February 4, 2020
Minister Eby, David Minister of Attorney General February 4, 2020
Public Agency Health February 4, 2020
Public Agency Mental Health and Addictions February 4, 2020

Name: Warrington, John
 
February 4, 2020  

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Development, establishment, amendment or termination of any program, policy or decision

Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness to government officials of biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for biosimilars.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency Health February 4, 2020
Public Agency Provincial Health Services Authority February 4, 2020
Public Agency University of British Columbia February 4, 2020